These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36145271)

  • 1. Identification of Novel Aryl Carboxamide Derivatives as Death-Associated Protein Kinase 1 (DAPK1) Inhibitors with Anti-Proliferative Activities: Design, Synthesis, In Vitro, and In Silico Biological Studies.
    Elkamhawy A; Paik S; Ali EMH; Hassan AHE; Kang SJ; Lee K; Roh EJ
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity.
    Elsherbeny MH; Elkamhawy A; Nada H; Abdellattif MH; Lee K; Roh EJ
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF
    Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH
    Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.
    Farag AK; Hassan AHE; Jeong H; Kwon Y; Choi JG; Oh MS; Park KD; Kim YK; Roh EJ
    Eur J Med Chem; 2019 Jan; 162():161-175. PubMed ID: 30445265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the prognostic and physiological functions of death associated protein kinase 1 in breast cancer.
    Huang Y; Lin M; Chen X; Huang C; Zhang X; Chen L; Wu K; Chen Y; Zhu Y; Lin Y
    Oncol Lett; 2018 Jun; 15(6):8261-8268. PubMed ID: 29805560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1.
    Yokoyama T; Kusaka K
    FEBS J; 2023 Sep; 290(18):4465-4479. PubMed ID: 37171222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
    Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
    Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an
    Firoz A; Talwar P
    J Biomol Struct Dyn; 2024 Jul; 42(11):5686-5698. PubMed ID: 37387600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and optimization of isoliquiritigenin as a death-associated protein kinase 1 inhibitor.
    Yokoyama T; Hisatomi K; Oshima S; Tanaka I; Okada T; Toyooka N
    Eur J Med Chem; 2024 Dec; 279():116836. PubMed ID: 39243455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents
    Nemr MTM; AboulMagd AM; Hassan HM; Hamed AA; Hamed MIA; Elsaadi MT
    RSC Adv; 2021 Jul; 11(42):26241-26257. PubMed ID: 35479426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and thermodynamic analyses of interactions between death-associated protein kinase 1 and anthraquinones.
    Yokoyama T; Wijaya P; Kosaka Y; Mizuguchi M
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):438-446. PubMed ID: 32355040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer.
    Sun Y; Sun Y; Wang L; Wu T; Yin W; Wang J; Xue Y; Qin Q; Sun Y; Yang H; Zhao D; Cheng M
    Eur J Med Chem; 2022 Aug; 238():114424. PubMed ID: 35576702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospecting for Breast Cancer Blood Biomarkers: Death-Associated Protein Kinase 1 (DAPK1) as a Potential Candidate.
    Arko-Boham B; Owusu BA; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Adams AR; Gyasi RK; Adu-Aryee NA; Mahmood S
    Dis Markers; 2020; 2020():6848703. PubMed ID: 32566040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrol.
    Yokoyama T; Suzuki R; Mizuguchi M
    IUCrJ; 2021 Jan; 8(Pt 1):131-138. PubMed ID: 33520249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death Associated Protein Kinase 1 (DAPK1): A Regulator of Apoptosis and Autophagy.
    Singh P; Ravanan P; Talwar P
    Front Mol Neurosci; 2016; 9():46. PubMed ID: 27445685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
    Aberg M; Johnell M; Wickström M; Siegbahn A
    Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.
    Luo XJ; Li LL; Deng QP; Yu XF; Yang LF; Luo FJ; Xiao LB; Chen XY; Ye M; Liu JK; Cao Y
    Eur J Cancer; 2011 Jan; 47(2):316-25. PubMed ID: 20943371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.